Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial

Nephrology Dialysis Transplantation, 05/24/2012

In comparison with low–flux haemodialysis, convective treatments did not significantly improve haemoglobin levels or erythropoiesis–stimulating agent (ESA) resistance. The main sources of variability were participating centres, ESA dose and the underlying disease.

Print Article Summary Cat 2 CME Report